Key result
Pulsed-field ablation terminates refractory IART in complex congenital heart disease with no recurrence at ~10 months.
Why the study?
Supraventricular tachycardia causes high morbidity in adult congenital heart disease, but ablation poses challenges due to access difficulties, circuit variations, and risk of damaging surrounding structures.
Case Report (n=1)
No
Pulsed-field ablation using a steerable mapping and ablation catheter can safely and effectively treat complex intra-atrial re-entrant tachycardias in adults with complex congenital heart disease.
Pulsed-field ablation may succeed where radiofrequency fails in complex CHD-related IART; hypothesis-generating pending larger studies.
BACKGROUND: Supraventricular tachycardia is common in patients with adult congenital heart disease and carries a high morbidity. Ablation of these arrhythmias is an effective treatment strategy, but difficulty accessing the cardiac chambers, variations in electroanatomical circuits, and concerns of damaging the surrounding structures can pose procedural challenges. CASE SUMMARY: A 45-year-old man with complex congenital heart disease and intra-atrial re-entrant tachycardia initially underwent ablation with radiofrequency energy but experienced clinical recurrence. He presented for a second procedure using pulsed-field ablation (PFA), which was successful. DISCUSSION: PFA is emerging as a safe and effective energy delivery system for ablation of different cardiac arrhythmias. It may be effective in adult congenital heart disease patients with atrial fibrillation. TAKE-HOME MESSAGE: PFA is safe and effective for treatment of supraventricular tachycardia in the adult congenital heart disease population.
No takes yet. Share an insight, caveat, or question.
Pipilas et al. (2026) conducted a case report in Intra-atrial re-entrant tachycardia in adult congenital heart disease (n=1). Pulsed-field ablation was evaluated on Arrhythmia termination and recurrence. Pulsed-field ablation successfully terminated refractory intra-atrial re-entrant tachycardia in a 45-year-old man with complex congenital heart disease, with no recurrence after 10 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: